Henry Schein, Inc. (HSIC) has been demonstrating robust performance with some mixed fundamentals. Its third quarter 2024 conference call has been scheduled and its Foundation 2024 Relief Fund has committed up to $500,000 for Southeast U.S. relief. The company has received a 'Moderate Buy' recommendation from analysts and assembled 23,000 hygiene kits for families in need. Yet, its stock has underperformed relative to competitors. SG Americas Securities LLC acquired shares in HSIC, which faced cyberattack and macroeconomic challenges. Its Pink Program raised $2 million for cancer patients over 18 years and it was named to the FORTUNE®'s 'Change the World' list. The firm is boosting its emergency preparedness efforts with a new 'Prepare to Care' program and now serves as exclusive distributor of Curodont to dental organizations. HSIC's Q2 results beat estimates but they also faced issues with a cyberattack, affecting their recovery. The firm was part of the FDI World Dental Congress 2024 in Istanbul, Turkey, while Lorelei McGlynn sold $1.46M in HSIC stock. Lastly, they completed an acquisition of TriMed, Inc.
Henry Schein HSIC News Analytics from Mon, 11 Oct 2021 07:00:00 GMT to Fri, 04 Oct 2024 21:21:00 GMT -
Rating 5
- Innovation 3
- Information 6
- Rumor 1
